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 Sentinel Lymph Nodes and 
Lymphatic Vessels:  Noninvasive 
Dual-Modality in Vivo Mapping 
by Using Indocyanine Green in 
Rats—Volumetric Spectroscopic 
Photoacoustic Imaging and Planar 
Fluorescence Imaging 1 
 Chulhong  Kim , PhD
 Kwang Hyun  Song , PhD
 Feng  Gao , PhD
 Lihong V.  Wang ,  PhD 
 Purpose: To noninvasively map sentinel lymph nodes (SLNs) and 
lymphatic vessels in rats in vivo by using dual-modality 
nonionizing imaging—volumetric spectroscopic photoa-
coustic imaging, which measures optical absorption, and 
planar fl uorescence imaging, which measures fl uorescent 
emission—of indocyanine green (ICG).
 Materials and 
Methods: 
Institutional animal care and use committee approval was 
obtained. Healthy Sprague-Dawley rats weighing 250 2 420 g 
(age range , 60 2 120 days) were imaged by using volumetric 
photoacoustic imaging ( n = 5) and planar fl uorescence imaging 
( n = 3) before and after injection of 1 mmol/L ICG. Student 
paired  t tests based on a logarithmic scale were performed to 
evaluate the change in photoacoustic signal enhancement of 
SLNs and lymphatic vessels before and after ICG injection. The 
spatial resolutions of both imaging systems were compared at 
various imaging depths (2–8 mm) by layering additional bio-
logic tissues on top of the rats in vivo. Spectroscopic photoa-
coustic imaging was applied to identify ICG-dyed SLNs.
 Results: In all fi ve rats examined with photoacoustic imaging, SLNs 
were clearly visible, with a mean signal enhancement of 5.9 
arbitrary units (AU)  6 1 .8 (standard error of the mean) 
( P  , .002) at 0.2 hour after injection, while lymphatic ves-
sels were seen in four of the fi ve rats, with a signal en-
hancement of 4.3 AU  6 0.6 ( P = .001). In all three rats 
examined with fl uorescence imaging, SLNs and lymphatic 
vessels were seen. The average full width at half maxi-
mum (FWHM) of the SLNs in the photoacoustic images 
at three imaging depths (2, 6, and 8 mm) was 2.0 mm  6 
0.2 (standard deviation), comparable to the size of a dis-
sected lymph node as measured with a caliper. However, 
the FWHM of the SLNs in fl uorescence images widened 
from 8 to 22 mm as the imaging depth increased, owing to 
strong light scattering. SLNs were identifi ed spectroscopi-
cally in photoacoustic images.
 Conclusion: These two modalities, when used together with ICG, have 
the potential to help map SLNs in axillary staging and to help 
evaluate tumor metastasis in patients with breast cancer.
 q RSNA, 2010
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Sprague-Dawley rats that weighed 250 2 
420 g (age range, 60 2 120 days; fi ve rats 
for photoacoustic imaging and three for 
fl uorescence imaging) were used in all 
imaging experiments. First, the rats were 
given a mixture of ketamine (Ketaset; 
Fort Dodge Animal Health, Fort Dodge, 
Iowa) (85 mg per kilogram of body 
weight) and xylazine (AnaSed; Akorn, 
Decatur, Ill) (15 mg/kg) for anesthesia. 
After depilation of the axillary region, the 
rats were positioned atop a homemade 
holder. During the experiments, the rats 
were fully anesthetized by using a vapor-
ized isofl urane system (Euthanex, Palmer, 
Pa) that provided 1 L/min oxygen and 
0.75% isofl urane; their vital signs were 
managed by using a pulse oximeter. 
After image acquisition, the animals were 
euthanized with an overdose of pento-
barbital (Sleepaway; Fort Dodge Animal 
Health); the SLNs were then dissected 
for visual verifi cation of ICG uptake. 
ICG (as 0.2 mL of 1 mmol/L ICG [Car-
diogreen;  Sigma-Aldrich, St Louis, Mo]) 
was injected intradermally into the left 
forepaw pad of the rat.  Figure 1 c shows 
the optical spectrum of 1 mmol/L ICG 
( 14 ). 
well as the maximum imaging depth, is 
scalable with ultrasonic frequency within 
the reach of diffuse photons. In biologic 
tissues the imaging depth can be up to 
a few centimeters deep. Methylene blue 
and gold nanoparticles have been ap-
plied to identify SLNs in rats with photo-
acoustic imaging ( 11,12 ). However, light 
is slightly more strongly scattered at the 
peak absorption wavelength of methyl-
ene blue, 677 nm, than light in the near-
infrared region. The methylene blue dye 
can cause chemical mastitis, as well as 
photodamage under intense light. Fur-
thermore, gold nanoparticles are not yet 
approved by the U.S. Food and Drug Ad-
ministration for clinical applications. 
 To date, to our knowledge, no studies 
have been reported about the feasibility 
of photoacoustic imaging with indocya-
nine green (ICG) for identifying SLNs and 
lymphatic vessels. ICG is Food and Drug 
Administration–approved for determin-
ing human cardiac output, hepatic func-
tion, and blood fl ow and for ophthalmic 
angiography. Because ICG has a moder-
ate fl uorescence quantum yield (approxi-
mately 10%) and because fl uorescence 
and photoacoustic signals increase and 
decrease with the fl uorescence quantum 
yield, respectively, ICG can be used as a 
contrast agent for both fl uorescence im-
aging ( 13 ) and photoacoustic imaging. 
Thus, the purpose of this study was to 
noninvasively map SLNs and lymphatic 
vessels in rats in vivo by using dual-
modality (volumetric spectroscopic pho-
toacoustic imaging, which measures opti-
cal absorption, and planar fl uorescence 
imaging, which measures fl uorescent 
emission) nonionizing imaging of ICG. 
 Materials and Methods 
 Animal Handling and Dye Preparation 
 Institutional animal care and use com-
mittee approval was obtained. Healthy 
 To reduce the side effects of axillary lymph node dissection, sentinel lymph node (SLN) biopsy (SLNB) 
has become the standard method for 
staging disease in patients with breast 
cancer ( 1 ). Although SLNB with blue 
dye and/or radioactive tracers has an 
identifi cation rate of 90%–95% and a 
sensitivity of 88%–95%, these methods 
involve the use of ionizing radiation and 
are invasive (2,3). Moreover, they can 
fail to help identify axillary disease ow-
ing to a false negative rate of 5%–10% 
( 2,3 ). Furthermore, while SLNB is less 
invasive than axillary lymph node dis-
section, it still poses a risk of postoper-
ative complications: seroma formation, 
lymphedema, and motion limitation ( 4 ). 
As an alternative to SLNB, ultrasono-
graphically (US)-guided fi ne-needle as-
piration biopsy (FNAB) has been utilized 
( 5 ). Although US-guided FNAB is less in-
vasive, this technique requires accurate 
identifi cation of the SLN. Therefore, 
there is still a pressing need to develop 
an accurate, nonionizing, and noninva-
sive detection method for lymph node 
assessment. In addition to lymph node 
assessment in tumor studies, lymphatic 
vessels play an important role in lym-
phatic metastasis ( 6,7 ). Although both 
lymphatic and vascular systems contrib-
ute to tumor metastasis, the studies of 
lymphatic systems have been hindered 
by technical limitations. Fluorescence 
optical microscopy ( 8 ) successfully im-
ages lymphatic capillaries but suffers 
from poor spatial resolution because of 
strong light scattering in relatively deep 
tissues. 
 Photoacoustic imaging (Appendix E1 
[online]) is an emerging hybrid modal-
ity that can provide strong endogenous 
and exogenous optical absorption con-
trasts with high ultrasonic spatial reso-
lution ( 9,10 ). The image resolution, as 
 Implication for Patient Care 
 Volumetric spectroscopic photoa- n
coustic imaging with ICG can 
potentially be used as a clinical 
tool for staging disease in 
patients with breast cancer. 
 Advance in Knowledge 
 Nonionizing volumetric spectro- n
scopic photoacoustic imaging can 
noninvasively map sentinel lymph 
nodes and lymphatic vessels with 
high spatial resolution in healthy 
rats with the use of indocyanine 
green (ICG) in vivo. 
 Published online 
 10.1148/radiol.10090281 
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 Abbreviations: 
 AU = arbitrary units 
 FWHM = full width at half maximum 
 ICG = indocyanine green 
 MAP = maximum amplitude projection 
 1D = one-dimensional 
 SLN = sentinel lymph node 
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30-mm fi eld of view, the acquisition time 
was 23 minutes. 
 To investigate the feasibility of using 
ICG for volumetric in vivo mapping of 
SLNs and lymphatic vessels, the left axil-
lae of fi ve rats were noninvasively imaged 
by using the photoacoustic imaging sys-
tem ( Fig 2 ). Prior to the administration 
of ICG, control images were obtained; a 
series of photoacoustic images was then 
acquired after the injection of ICG. We 
monitored the fi rst rat with photoacous-
tic imaging for 1 hour. The second rat 
was monitored for 3.2 hours to image 
the dynamics of SLNs and lymphatic 
vessels related to ICG injection, and the 
photoacoustic signals within those sites 
were quantifi ed by spatially averaging lo-
cal photoacoustic signals. Two other rats 
were fi rst imaged for 1 hour to observe 
SLNs and lymphatic vessels and then used 
to observe image degradation with addi-
tional biologic tissues. The last rat was 
fi rst imaged for 2.2 hours and then used 
for spectroscopic photoacoustic imaging. 
The statistical analysis showing photoa-
coustic signal enhancement in SLNs and 
lymphatic vessels at 0.2 and 1 hour af-
ter injection was based on the imaging 
results in these fi ve rats. Photoacoustic 
signal enhancement was defi ned as the 
average photoacoustic signal intensity 
within the areas of SLNs and lymphatic 
vessels after ICG injection divided by the 
photoacoustic signal intensity within the 
same regions before injection. 
 Planar Fluorescence Imaging System 
and Experiment 
 The planar fl uorescence imaging sys-
tem is shown in  Figure 1b . The 784-nm, 
80-mW light beam (Thorlabs,  Newton, 
NJ) was expanded by a concave lens and 
illuminated the axilla of the  animal. A fl u-
orescent band-pass fi lter (F10–830; CVI 
Laser, Albuquerque, NM) was mounted 
onto the front of a cooled charge-coupled 
device camera (BU401–BR; Andor Tech-
nology, South Windsor, Conn). Emitted 
fl uorescent light was collected by the 
camera. Three new rats were examined 
by using the fl uorescence imaging system; 
two for SLN mapping until 1 hour after 
ICG injection and one for the study of 
spatial resolution degradation with addi-
tional chicken breast tissue. We quantifi ed 
(V308; Panametrics-NDT, Waltham, 
Mass). The spatial resolutions at 19 mm 
deep in biologic tissues were 144 µm in 
the axial direction and 560 µm in the 
transverse direction ( 15 ). One-dimensional 
(1D) depth-resolved (A-line) images were 
acquired by measuring the time of arrival 
of photoacoustic signals. By scanning tar-
gets in two transverse  directions (yield-
ing two-dimensional depth-resolved im-
ages, called B-scans),  three-dimensional 
images, which represented the optical 
absorption heterogeneities of tissues, 
were formed. The acquired volumetric 
images were expressed in two forms: a 
maximum amplitude projection (MAP) 
image, which projected the maximum 
signal along each A-line onto the corre-
sponding x-y plane, and a true volumetric 
image processed with software (Volview; 
Kitware, Clifton Park, NY). The scanning 
step sizes for the x and y directions were 
200 and 400 µm, respectively. For a 25  3 
 Volumetric Photoacoustic Imaging 
System and Experiment 
 The volumetric photoacoustic imaging 
system is shown in  Figure 1a ( 15 ). The 
light was delivered from a tunable dye la-
ser (ND6000; Continuum, Santa Clara, 
Calif) pumped by a Q-switched Nd:YAG 
laser (LS-2137; LOTIS, Minsk, Belarus) 
with a 6-nanosecond pulse duration and 
a 10-Hz pulse repetition rate. A light 
wavelength of 668 nm was used for most 
of the experiments, but both 618- and 
668-nm optical wavelengths were used 
for spectroscopic SLN identifi cation. 
Formed by a concave lens, a spherical 
conical lens, and an optical condenser, 
the dark-fi eld light illumination was co-
axially aligned with the US focus in water 
( 16 ). The light fl uence on the skin was 
3.4 mJ/cm 2 , within the American National 
Standards Institute limit ( 17 ). Generated 
photoacoustic waves were detected by 
a  single-element 5-MHz US transducer 
 Figure 1 
  
 Figure 1:  (a) Experimental setup of the photoacoustic imaging system.  (b) Experimental setup of the 
fl uorescence imaging system.  CCD = charge-coupled device.  (c) Optical spectrum of 1 mmol/L ICG. A 
wavelength of 668 nm was used for photoacoustic imaging experiments. For spectroscopic photoacoustic 
imaging, wavelengths of 618 and 668 nm were chosen. 
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pothesis was that the spatial resolution 
of the photoacoustic imaging system 
would be approximately maintained at 
the relatively low ultrasonic frequency 
even though the imaging depth was 
extended, since the resolution is de-
termined by ultrasonic parameters 
( 15 ). However, the spatial resolution 
of fl uorescence imaging is expected to 
become worse because of strong light 
scattering. We compared the 1D pro-
fi les taken from each photoacoustic 
MAP image and planar fl uorescence 
image. Those 1D profi les were shifted 
and normalized according to the equa-
tion ? ? ? ?bg max bg? ?S S S S , where  S de-
notes the photoacoustic or fl uorescence 
for photoacoustic imaging and one rat 
for fl uorescence imaging, 1 hour after 
the ICG injection we added chicken 
breast tissue on top of the axillary re-
gion. Most SLNs are about 2 mm deep 
below the skin surface in the axillary 
region in rats. After we added one 3–4-
mm-thick layer of chicken breast, the 
depth was increased to 5–6 mm. By 
adding a second 2–3-mm-thick layer of 
chicken breast, we extended the total 
depth to approximately 8 mm. Our hy-
fl uorescent signals by spatially  averaging 
local fl uorescent intensities within the SLN 
for 1 hour after the injection in a rat. The 
error bars were based on the variation of 
fl uorescent intensities within the SLN. 
 Image Degradation Study with Additional 
Biologic Tissues 
 We examined the degradation of spatial 
resolution in both photoacoustic and 
fl uorescence images when the imaging 
depth was incremented. Using two rats 
 Figure 2 
  
 Figure 2: Volumetric photoacoustic imaging.  (a) Control MAP image acquired before ICG injection in the 
axillary region. Blood vessels  (BV) are seen.  (b) Photoacoustic image acquired 0.2 hour after injection. Lym-
phatic vessels, as well as an SLN, are seen.  (c) Three-dimensional photoacoustic image processed from the 
0.7-hour postinjection data shown in Figure E1 (online).  (d) Graph shows results of comparison of photoa-
coustic  (PA) signals within the SLN and lymphatic vessels  (LV) versus time before and after the injection in a 
given rat. The photoacoustic signals were normalized by the photoacoustic signals of adjacent blood vessels. 
 (e) Graph shows results of statistical comparison of photoacoustic signal enhancement in the background 
 (BG) ( n = 5), SLN ( n = 5), and lymphatic vessels ( n = 4) at 0.2 and 1 hour after injection. The  P values for the 
SLN and lymphatic vessels, respectively, were less than .002 and .001 at 0.2 hour after injection and less 
than .001 and .13 at 1 hour after injection.  (f)  Photographs of rat before dissection (top), axillary region after 
dissection (bottom left), and ICG-dyed lymph node (bottom right).  a.u. = Arbitrary units (AU), error bars in 
 d = standard deviation, error bars in  e = standard error of the mean.
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ter injection. The photoacoustic signals 
in two lymphatic vessel locations were 
1.08 AU  6 0.048 (location 1) and 1.09 
AU  6 0.073 (location 2) at 0.2 hour af-
ter injection, which represented nine- 
and 11-fold increases, respectively, over 
the values before injection. However, 
at 1.2 hours after injection, the signals 
(0.51 AU  6 0.034 for location 1 and 
0.24 AU  6 0.001 for location 2) had de-
creased by 53% and 78%, respectively, 
from those at 0.2 hour after injection. 
In addition, after 1.5 hours, the pho-
toacoustic signals from the SLN and 
the lymphatic vessels fl uctuated slightly, 
moving in opposition. These results can 
be explained by the compression and 
expansion phases of lymphatic vessels. 
Furthermore, the ICG started to diffuse 
to a second lymph node at 1.7 hours 
after injection (Figure E1 [online]). 
 Figure 2e shows the results of a statisti-
cal comparison of photoacoustic signal 
enhancement within the background, 
SLN, and lymphatic vessels at 0.2 and 
1 hour after injection. In all fi ve rats 
imaged with photoacoustic imaging, 
SLNs were clearly visible, with a pho-
toacoustic signal enhancement of 5.9 
AU  6 1.8 (standard error of the mean) 
( P  , .002) at 0.2 hour after injection, 
while lymphatic vessels were seen in 
four of the fi ve rats, with a photoacous-
tic signal enhancement of 4.3 AU  6 0.6 
( P = .001). At 1 hour after injection, the 
photoacoustic signal enhancement from 
the SLN increased to 7.1 AU  6 2.2 
( P  , .001), but the enhancement from 
the lymphatic vessels decreased to 1.9 
AU  6 0.2 ( P = .13). The greenish lymph 
node dissected after photoacoustic im-
aging confi rmed ICG uptake ( Fig 2f ), 
because normal lymph nodes do not 
have any green color. 
 Planar Fluorescence Imaging 
 By using the planar fl uorescence imag-
ing system, the dynamics of ICG uptake 
by the SLN were monitored. A large 
amount of ICG was trapped by the lym-
phatic vessels right after the injection. 
As time passed, the fl uorescent signal 
within the SLN overwhelmed the signal 
from the lymphatic vessels and reached 
a steady state 40 minutes after the 
injection ( Fig 3 ). 
were used for the assessment of lym-
phatic vessels, since the lymphatic ves-
sels were not visible in one experiment. 
The photoacoustic signal enhancement 
of SLNs and lymphatic vessels at 0.2 
hour after injection was calculated, 
and then logarithmic transformation 
was applied to the photoacoustic signal 
enhancement for a better satisfaction 
of the normality assumption. Student 
paired  t tests were performed to com-
pare the pre- and postinjection differ-
ences. Note that the use of the paired 
 t test based on a logarithmic scale 
was also equivalent to testing whether 
the photoacoustic signal enhancements 
(ie, the fold changes) of SLNs and 
lymphatic vessels were equal to 1. 
Statistical analyses were performed 
by using standard software (SAS, 
version 9; SAS Institute, Cary, NC). A 
 P value of less than .05 was considered 
to indicate a signifi cant difference, and 
all statistical tests were two sided. 
 Results 
 Volumetric Photoacoustic Imaging 
 Figure 2a shows the control image in 
one rat before the administration of 
ICG; the image depicts the surrounding 
vascular structures. The average photo-
acoustic signal enhancement from blood 
vessels was 5.1 AU  6 0.7 (standard er-
ror of the mean) (Figure E2 [online]). In 
 Figure 2b , the SLN and lymphatic ves-
sels, along with the surrounding blood 
vessels, are clearly shown at 0.2 hour 
after injection.  Figure 2c shows a volu-
metric rendering of the data at 0.7 hour 
after injection (Figure E1 [online]). In 
addition to the SLN and lymphatic ves-
sels, the functioning of the lymphatic 
valves can be inferred because lym-
phatic vessels were expanded immedi-
ately after the injection of ICG and then 
compressed. The photoacoustic signal 
in the SLN at 0.2 hour after injection 
was 0.96 AU  6 0.038 (standard devia-
tion), a 7.4-fold increase over the value 
of 0.13 AU  6 0.13 before injection ( Fig 
2d and Figure E1 [online]). Further-
more, the signal (1.13 AU  6 0.038) at 
1.2 hours after injection had increased 
by 18% over the signal at 0.2 hour af-
signal,  S max denotes the maximum signal, 
and  S bg denotes the background sig-
nal. The full widths at half maximum 
(FWHMs) of those 1D profi les, which 
were closely correlated with the spatial 
resolutions of both imaging systems, 
were estimated. 
 Spectroscopic Photoacoustic Imaging 
 Prior to the injection of ICG, the SLN 
and lymphatic vessels were not visible 
in control images. After the injection of 
ICG, the SLN and lymphatic vessels were 
diffi cult to distinguish from the surround-
ing blood vasculature without a proper 
control image. However, the SLN and 
lymphatic vessels can be distinguished 
from the surrounding blood vasculature 
by collecting images at two wavelengths 
(668 and 618 nm) after ICG injection. 
Because of the different absorption coef-
fi cients of blood and ICG at these optical 
wavelengths, lymphatic structures can 
be effectively differentiated from blood 
vessels by comparing the images ac-
quired. First, we imaged the axillary re-
gion of one rat at 668 nm until 2.2 hours 
after the injection, and then we imaged 
the same region at 618 nm. After that, 
we switched the wavelength back to 668 
nm to confi rm that the disappeared pho-
toacoustic signals within the SLNs came 
from the wavelength switch instead of 
from ICG clearance. We quantifi ed pho-
toacoustic signals by spatially averaging 
local photoacoustic amplitudes within 
the SLN and the adjacent blood vessels 
for 3.2 hours after the injection. The er-
ror bars were based on the variation of 
the photoacoustic signals within the SLN 
and blood vessels. Blood has more ab-
sorption at 618 nm than at 668 nm ( 18 ), 
so the photoacoustic signals at 618 nm 
were expected to be stronger in blood. 
However, ICG has much less absorp-
tion at 618 nm than at 668 nm ( 14 ), so 
the photoacoustic signals in ICG-dyed 
SLNs at 668 nm were expected to be 
stronger. 
 Statistical Analysis 
 The results from all fi ve rats imaged 
with photoacoustic imaging were used 
for the statistical assessment of SLNs, 
whereas the results from only four rats 
imaged with photoacoustic imaging 
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Food and Drug Administration–approved 
dye for determining human  cardiac out-
put, hepatic function, and blood fl ow 
and for ophthalmic angiography. Unlike 
methylene blue, it has less potential 
for chemical side effects and photo-
damage. By  applying a spectroscopic 
approach, this photoacoustic imaging 
system is potentially more useful in 
clinical conditions. 
 Images from both techniques clearly 
show SLNs, lymphatic vessels, and the 
course and fl ow of lymphatic vessels. 
The lymphatic vessels are expanded 
and compressed passively by the peri-
odic motion of adjunct structures. Dur-
ing the expansion, the initial lymphatic 
vessel traps a large amount of ICG 
 owing to the opening of primary lym-
phatic valves, and this allows an infl ux 
of ICG to the initial lumen. At the same 
time, the secondary valve, the traditional 
intralymphatic valve, inside the initial 
channel is closed. During the compres-
sion, the secondary valve of the current 
lumen opens, and the dye is transported 
to the next lumen ( 19 ). Although the 
fl uorescence images clearly show sub-
cutaneous SLNs and lymphatic ves-
sels, as Kitai et al ( 20 ) and Miyashiro 
a sudden increase right after the injec-
tion compared with the signal (0.05 AU 
 6 0.009) before injection, and slowly 
decreased as time passed. When the 
wavelength was changed to 618 nm, 
the photoacoustic signal decreased to 
0.04 AU  6 0.007, close to the signal 
level seen with no ICG present. The sig-
nal again increased to 0.5 AU  6 0.02 
after the wavelength was switched to 
668 nm. In contrast, the photoacoustic 
signals within the adjacent blood vessel 
remained at 0.77 AU  6 0.03 at 668 nm, 
not showing any variation due to ICG 
injection. Then, the signal increased to 
1.0 AU  6 0.013 when the wavelength 
was changed to 618 nm. The signal de-
creased to 0.73 AU  6 0.15 after the 
wavelength was switched to 668 nm. 
These variations agree well with the 
optical spectrum of blood. 
 Discussion 
 Using volumetric spectroscopic photo-
acoustic and planar fl uorescence imaging, 
we have demonstrated the feasibility of 
noninvasive in vivo dual-modality map-
ping of SLNs and lymphatic vessels with 
ICG. Unlike gold nanoparticles, ICG is a 
 Image Degradation Study with Additional 
Biologic Tissues 
 Figure 4 shows MAP and correspond-
ing B-scan photoacoustic images at 
three different SLN depths after the 
injection. The SLNs are clearly seen 
in the MAP and B-scan images. The 
spatial resolution was fairly well main-
tained, although the imaging depth was 
increased. The average FWHM of the 
three 1D profi les in  Figure 4b was 2.0 
mm  6 0.2 (standard deviation), which 
is comparable to the measured size of a 
dissected lymph node.  Figure 4c shows 
fl uorescent images at three SLN depths. 
As the imaging depth was extended, 
the fl uorescent images became blurred. 
The FWHMs of the three 1D profi les 
widened from 8 to 22 mm as the imag-
ing depth increased ( Fig 4d ). 
 Spectroscopic Photoacoustic Imaging 
 The image representing subtraction of 
the 0.2-hour postinjection image at 
668 nm from the 2.2-hour postinjec-
tion image at 618 nm showed the SLN 
and lymphatic vessels ( Fig 5 , Figure E3 
[online]). The quantifi ed photoacous-
tic signal within the SLN was 1.0 AU 
 6 0.07 (standard deviation), which was 
 Figure 3 
  
 Figure 3:  (a) Coronal planar fl uorescence images acquired before injection  (Control) and 0, 5, and 30 minutes after injection of 
ICG in a rat.  LV = lymphatic vessel.  (b) Bar graph shows changes in fl uorescence signals within the SLN region after the injection. 
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nary studies of the uptake dynamics of 
ICG on SLNs by using both imaging sys-
tems, further quantitative studies are 
required on the uptake and clearance 
times of ICG and the uptake amount as 
a function of ICG injection concentra-
tion. Moreover, although ICG is a near-
infrared dye, the peak absorption of 
ICG in this study was shifted to 700 nm 
because of the aggregation of ICG mol-
ecules ( 14,25 ). Thus, more stable ICG 
is not suitable for monitoring the dy-
namics of ICG in SLNs and lymphatic 
vessels compared with fl uorescence 
imaging. However, this is not a funda-
mental limitation of photoacoustic im-
aging. The time limitation can be easily 
overcome if a US array ( 22,23 ) is used 
as a detector and/or a high frame rate 
of laser pulses with a high-speed scan-
ning system ( 24 ) is used. In addition, 
although we have conducted prelimi-
et al ( 21 ) reported, it is diffi cult to 
map deeply positioned axillary lymph 
nodes noninvasively because of poor 
spatial resolution. In addition, to fi nd a 
positive sentinel node using a molecular 
targeted contrast agent without biopsy, a 
high-spatial-resolution imaging technique 
is necessary. 
 Our study had limitations. Because of 
the slow image acquisition (23 minutes), 
this photoacoustic imaging system 
 Figure 4 
  
 Figure 4: Comparison of spatial resolutions between photoacoustic and fl uorescence images with increases in imaging depth 
increments.  (a) Photoacoustic MAP (top row) and corresponding depth-resolved B-scan (bottom row) images of SLNs at three 
depths.  (b) Graph shows results for three 1D profi les taken from along the dotted lines in the MAP images in  a .  (c) Fluores-
cence images of SLNs at three depths.  (d) Graph shows results for three 1D profi les taken from along the dashed lines in  c . 
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magnetic contrast agent .  J Natl Cancer Inst 
 2004 ; 96 ( 9 ): 703 – 708 . 
  2 .  McMasters  KM ,  Tuttle  TM ,  Carlson  DJ , 
 et al .  Sentinel lymph node biopsy for breast 
cancer: a suitable alternative to routine ax-
illary dissection in multi-institutional prac-
tice when optimal technique is used .  J Clin 
Oncol  2000 ; 18 ( 13 ): 2560 – 2566 . 
  3 .  Ung  OA .  Australasian experience and 
trials in sentinel lymph node biopsy: the 
RACS SNAC trial .  Asian J Surg  2004 ; 27 ( 4 ):
 284 – 290 . 
  4 .  Purushotham  AD ,  Upponi  S ,  Klevesath  MB , 
 et al .  Morbidity after sentinel lymph node 
biopsy in primary breast cancer: results 
from a randomized controlled trial .  J Clin 
Oncol  2005 ; 23 ( 19 ): 4312 – 4321 .  
  5 .  Krishnamurthy  S ,  Sneige  N ,  Bedi  DG , 
 et al .  Role of ultrasound-guided fi ne-needle 
aspiration of indeterminate and suspicious 
axillary lymph nodes in the initial staging of 
of the described noninvasive dual-
modality method of SLN identifi cation 
and  percutaneous biopsy of the identifi ed 
SLNs would allow clinicians the ability 
to diagnose the presence or absence 
of malignancy and direct further treat-
ment on the basis of those fi ndings. 
 In summary, noninvasive dual-modality 
(volumetric spectroscopic photoacoustic 
and planar fl uorescence imaging) in vivo 
mapping of SLNs and lymphatic vessels 
using ICG as a contrast agent was suc-
cessfully accomplished in rats. 
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